492 related articles for article (PubMed ID: 9747263)
1. [Kasabach-Merritt syndrome on a congenital tufted angioma].
Enjolras O; Wassef M; Dosquet C; Drouet L; Fortier G; Josset P; Merland JJ; Escande JP
Ann Dermatol Venereol; 1998 Apr; 125(4):257-60. PubMed ID: 9747263
[TBL] [Abstract][Full Text] [Related]
2. [Kasabach-Merritt syndrome of the leg associated with osteolysis or Gorham sign].
Kerhoas Nicolas CK; Le Bidaut M; Dosquet C; Enjolras O; Stalder JF
Ann Dermatol Venereol; 1997; 124(12):852-4. PubMed ID: 9732759
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
5. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
[TBL] [Abstract][Full Text] [Related]
6. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
7. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
8. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.
Enjolras O; Wassef M; Mazoyer E; Frieden IJ; Rieu PN; Drouet L; Taïeb A; Stalder JF; Escande JP
J Pediatr; 1997 Apr; 130(4):631-40. PubMed ID: 9108863
[TBL] [Abstract][Full Text] [Related]
9. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia.
Rangwala S; Wysong A; Tollefson MM; Khuu P; Benjamin LT; Bruckner AL
Pediatr Dermatol; 2014; 31(3):402-4. PubMed ID: 22937785
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging.
Hara K; Yoshida T; Kajiume T; Ohno N; Kawaguchi H; Kobayashi M
Pediatr Hematol Oncol; 2009; 26(5):375-80. PubMed ID: 19579084
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
12. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.
Harper L; Michel JL; Enjolras O; Raynaud-Mounet N; Rivière JP; Heigele T; De Napoli-Cocci S
Eur J Pediatr Surg; 2006 Oct; 16(5):369-72. PubMed ID: 17160787
[TBL] [Abstract][Full Text] [Related]
13. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
14. Angiosarcoma associated with a Kasabach-Merritt syndrome: report of two cases treated with paclitaxel.
Grellety T; Italiano A
Future Oncol; 2013 Sep; 9(9):1397-9. PubMed ID: 23980686
[TBL] [Abstract][Full Text] [Related]
15. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
López V; Martí N; Pereda C; Martín JM; Ramón D; Mayordomo E; Jordá E
Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Kasabach-Merritt phenomenon: the role of vincristine as monotherapy: report of a case.
Traivaree C; Lumkul R; Torcharus K; Krutuecho T; Sriphaisal T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S181-5. PubMed ID: 22934467
[TBL] [Abstract][Full Text] [Related]
17. [Congenital haemangiomas and other rare infantile vascular tumours].
Enjolras O; Picard A; Soupre V
Ann Chir Plast Esthet; 2006; 51(4-5):339-46. PubMed ID: 16997442
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome.
Brasanac D; Janic D; Boricic I; Jovanovic N; Dokmanovic L
Pathol Int; 2003 Sep; 53(9):627-31. PubMed ID: 14507321
[TBL] [Abstract][Full Text] [Related]
19. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
[TBL] [Abstract][Full Text] [Related]
20. Successful management of a small infant with Kasabach-Merritt phenomenon using vincristine: a case report.
Economou M; Papagianni A; Tsigka A; Papouli M; Kattamis A; Gompakis N; Papachristou F
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):777-9. PubMed ID: 24717422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]